Table 5 Distribution of EGFR Mutations in Non-Small Cell Lung Cancer Patients by mutation types
Country | Author | G719X mutation in exon 18 N (%) | Deletion on exon 19 N (%) | Insertion in exon 20 N (%) | L858R mutation on exon 21 N (%) |
|---|---|---|---|---|---|
Overall | 15 | 151 | 13 | 80 | |
Lebanon | Naderi et al. [9] | 1 (4.2%) | 12 (50.0%) | 1a (4.2%) | 10 (41.6%) |
Fakhruddin et al. [10] | 0 (0%) | 8 (88.9%) | 0 (0%) | 1 (11.1%) | |
Kattan et al. [11] | 1 (4.5%) | 11 (50%) | 1 (4.5%) | 9 (41.0%) | |
Egypt | Zaki et al. [12] | 0 (0%) | 11 (100%) | 0 (0%) | 0 (0%) |
Turkey | Unal et al. [13] | 0 (0%) | 7 (38.9%) | 9 (50%) | 2 (11.1%) |
Bircan et al. [14] | 0 (0%) | 7a (63.6%) | 0 (0%) | 4a (36.4%) | |
Saudi Arabia (SA) | Al-Kuraya et al. [15] | 0 (0%) | 0 (0%) | 1 (100%) | 0 (0%) |
SA-UAE-Qatar | Jazieh et al. [16] | 4a (6.1%) | 36 (54.5%) | 0 (0%) | 26 (39.4%) |
SA-UAE-Egypt | Jazieh et al. [17] | 7 (10.3%) | 38a (57.4%) | 0 (0%) | 21a (32.3%) |
Morocco | Errihani et al. [18] | 2 (6.9%) | 20 (68.95%) | 1 (3.45%) | 6 (20.7%) |